# Pfizer Inc. (PFE): SI in SEC Filings | SI Exposure > Pfizer Inc. (PFE): 71.4% of its 10-K, 10-Q and 8-K filings in Q4 2025 to Q3 2026 contain "artificial intelligence"; it has not written "super intelligence" yet. Source: https://tsio.si/exposure/pfe/ Updated: 2026-11-11 Publisher: The SI Observatory (tsio.si), run by the SI community, built by Codeflex 1. [Home](https://tsio.si/) 2. [SI Exposure](https://tsio.si/exposure/) 3. Pfizer Inc. (PFE) SI Exposure · Rank 7 of 100 · Health Care # Pfizer Inc. (PFE) and SI **10 of Pfizer Inc.'s 14 10-K, 10-Q and 8-K filings in the last four full quarters (Q4 2025 to Q3 2026) contain "artificial intelligence" or the new name: 71.4%, rank 7 of the 100 largest US companies.** It has not used the new name, "super intelligence" or "superintelligence", in any SEC filing so far. Counts come from SEC EDGAR full text search, Nov 11, 2026. Updated **Nov 11, 2026** · SEC CIK [78003](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000078003) · Sector **Health Care** By quarter [The full ranking](https://tsio.si/exposure/#ranking) [Share on X](https://x.com/intent/post?text=Pfizer+Inc.+and+SI%3A+71.4%25+of+its+10-K%2C+10-Q+and+8-K+filings+now+contain+the+phrase%2C+rank+7+of+100.+From+SEC+EDGAR%3A&url=https%3A%2F%2Ftsio.si%2Fexposure%2Fpfe%2F) - **Share, last 4 quarters**: 71.4% - **Filings with the phrase**: 10 - **New name, all time**: 0 - **Rank of 100**: 7 Over time ## Pfizer Inc. filings, quarter by quarter Since Q1 2023: how many 10-K, 10-Q and 8-K filings Pfizer Inc. made each quarter and how many contain "artificial intelligence" or "super intelligence" or "superintelligence". *Chart: Share of Pfizer Inc. 10-K, 10-Q and 8-K filings that contain either name. Per calendar quarter; Q4 2026 runs to Nov 11, 2026.* | Quarter | Filings | Old name | New name | Share | |---|---|---|---|---| | Q4 2026 | 3 | 2 | 0 | 66.7% | | Q3 2026 | 2 | 2 | 0 | 100.0% | | Q2 2026 | 5 | 3 | 0 | 60.0% | | Q1 2026 | 2 | 2 | 0 | 100.0% | | Q4 2025 | 5 | 3 | 0 | 60.0% | | Q3 2025 | 2 | 2 | 0 | 100.0% | | Q2 2025 | 4 | 2 | 0 | 50.0% | | Q1 2025 | 2 | 2 | 0 | 100.0% | | Q4 2024 | 4 | 3 | 0 | 75.0% | | Q3 2024 | 5 | 2 | 0 | 40.0% | | Q2 2024 | 4 | 2 | 0 | 50.0% | | Q1 2024 | 3 | 2 | 0 | 66.7% | | Q4 2023 | 6 | 0 | 0 | 0.0% | | Q3 2023 | 3 | 0 | 0 | 0.0% | | Q2 2023 | 5 | 0 | 0 | 0.0% | | Q1 2023 | 4 | 0 | 0 | 0.0% | 10-K, 10-Q and 8-K filings by calendar quarter. Old name: filings with "artificial intelligence". New name: filings with "super intelligence" or "superintelligence". A filing with both counts once in the share. ## Filings with the new name None yet. When Pfizer Inc. first files a document with "super intelligence" or "superintelligence", it appears here with a link. ## Latest filings with "artificial intelligence" 1. Nov 3, 2026 [8-K](https://www.sec.gov/Archives/edgar/data/78003/000007800326000125/pfe-9272026xex99.htm) 0000078003-26-000125 2. Nov 3, 2026 [10-Q](https://www.sec.gov/Archives/edgar/data/78003/000007800326000127/pfe-20260927.htm) 0000078003-26-000127 3. Aug 4, 2026 [8-K](https://www.sec.gov/Archives/edgar/data/78003/000007800326000094/pfe-6282026xex99.htm) 0000078003-26-000094 4. Aug 4, 2026 [10-Q](https://www.sec.gov/Archives/edgar/data/78003/000007800326000095/pfe-20260628.htm) 0000078003-26-000095 5. Jun 18, 2026 [8-K](https://www.sec.gov/Archives/edgar/data/78003/000007800326000087/pfe-20260618.htm) 0000078003-26-000087 6. May 5, 2026 [8-K](https://www.sec.gov/Archives/edgar/data/78003/000007800326000053/pfe-3292026xex99.htm) 0000078003-26-000053 7. May 5, 2026 [10-Q](https://www.sec.gov/Archives/edgar/data/78003/000007800326000054/pfe-20260329.htm) 0000078003-26-000054 8. Feb 26, 2026 [10-K](https://www.sec.gov/Archives/edgar/data/78003/000007800326000026/pfe-20251231.htm) 0000078003-26-000026 9. Feb 3, 2026 [8-K](https://www.sec.gov/Archives/edgar/data/78003/000007800326000005/pfe-12312025xex99.htm) 0000078003-26-000005 10. Dec 16, 2025 [8-K](https://www.sec.gov/Archives/edgar/data/78003/000007800325000167/pfe-12162025xexh99.htm) 0000078003-25-000167 11. Nov 4, 2025 [8-K](https://www.sec.gov/Archives/edgar/data/78003/000007800325000149/pfe-09282025xex99.htm) 0000078003-25-000149 12. Nov 4, 2025 [10-Q](https://www.sec.gov/Archives/edgar/data/78003/000007800325000150/pfe-20250928.htm) 0000078003-25-000150 Embed ## Put this card on any page A plain image that links back here: no script, no cookies. It shows the latest build's numbers and its source. Free to use under CC BY 4.0. Copy the embed ``` SI Exposure of Pfizer Inc.: 71.4% of its 10-K, 10-Q and 8-K filings contain "artificial intelligence" ``` ![SI Exposure card for Pfizer Inc.](https://tsio.si/exposure/pfe/card.svg) Compare ## Neighbors in the ranking and sector peers [Rank 5 · Health Care**Eli Lilly and Company**72.7% of filings · 0 with the new name](https://tsio.si/exposure/lly/) [Rank 6 · Technology**KLA Corporation**71.4% of filings · 0 with the new name](https://tsio.si/exposure/klac/) [Rank 8 · Telecommunications**Cisco Systems Inc.**66.7% of filings · 0 with the new name](https://tsio.si/exposure/csco/) [Rank 9 · Consumer Discretionary**McDonald's Corporation**66.7% of filings · 0 with the new name](https://tsio.si/exposure/mcd/) [Rank 13 · Health Care**Altria Group Inc.**61.5% of filings · 0 with the new name](https://tsio.si/exposure/mo/) [Rank 34 · Health Care**Gilead Sciences Inc.**35.7% of filings · 0 with the new name](https://tsio.si/exposure/gild/)